Skip to main content
micro-community-banner
 
  • Saved

Commented on 's Post

Registration is now open! Join the free, online lecture with live Q&A on Thursday 9/23 at 8PM ET

see more

Migraine - Remote Diagnosis & Treatment

Dr. Huma Sheikh, Board Certified Neurologist, Headache and Vascular Disorder Specialist of NY Neurology Medicine in New York City shares best practices and watch outs of treating migraine patients during ..... see more

Source : https://hopin.to/events/skipta-migraine-dx?ref=c9955f762ddf

  • Saved

made a Post

Assessment of cervical and ocular vestibular evoked myogenic potentials in migraine patients

Patients suffering from vestibular migraine (VM) are known to have various vestibular test abnormalities interictally and ictally. Recently, vestibular evoked myogenic potentials (VEMPs) have become accepted as a valid method ..... see more

Source : https://ejo.springeropen.com/articles/10.1186/s43163-020-00017-1

  • Saved

Aimovig®: One dose, once a month, designed to work 24/7 all month long to help prevent migraine in adults

In a usability study of the SureClick® autoinjector among adult migraine patients (N = 204):

  • 96% found the autoinjector easy to use2,†
  • 93% would recommend the autoinjector to other patients2,†

Aimovig® is an anti-CGRP therapy that includes one monthly dose designed to work all month long to help prevent migraine.

Click here for resources to help your Aimovig patients, including those you have started through telemedicine.

204 autoinjector-naïve adult migraine patients were evaluated in a usability study of the Aimovig SureClick® single-dose autoinjector by performing a simulated injection. Percentages were derived from a combination of patients who stated that they completely agree or somewhat agree on a 5-point Likert scale.2

Expand +

INDICATION

Aimovig® (erenumab-aooe) is indicated for the preventive treatment of migraine in adults.

IMPORTANT SAFETY INFORMATION

Contraindication: Aimovig® is contraindicated in patients with serious hypersensitivity to erenumab-aooe or to any of the excipients. Reactions have included anaphylaxis and angioedema.

Hypersensitivity Reactions: Hypersensitivity reactions, including rash, angioedema, and anaphylaxis, have been reported with Aimovig® in post marketing experience.  Most reactions were not serious and occurred within hours of administration, although some occurred more than one week after administration.  If a serious or severe reaction occurs, discontinue Aimovig® and initiate appropriate therapy. 

Constipation with Serious Complications: Constipation with serious complications has been reported following the use of Aimovig® in the postmarketing setting.  There were cases that required hospitalization, including cases where surgery was necessary.  The onset of constipation was reported after the first dose in a majority of these cases, but patients also reported later on in treatment.  Aimovig® was discontinued in most reported cases.  Constipation was one of the most common (up to 3%) adverse reactions reported in clinical studies.

Monitor patients treated with Aimovig® for severe constipation and manage as clinically appropriate.  Concurrent use of medications associated with decreased gastrointestinal motility may increase the risk for more severe constipation and the potential for constipation-related complications.

Hypertension: Development of hypertension and worsening of pre-existing hypertension have been reported following the use of Aimovig® in the postmarketing setting. Many of the patients had pre-existing hypertension or risk factors for hypertension. There were cases requiring pharmacological treatment and, in some cases, hospitalization. Hypertension may occur at any time during treatment but was most frequently reported within seven days of dose administration. In the majority of the cases, the onset or worsening of hypertension was reported after the first dose. Aimovig® was discontinued in many of the reported cases.

Monitor patients treated with Aimovig® for new-onset hypertension, or worsening of pre-existing hypertension, and consider whether discontinuation of Aimovig® is warranted if evaluation fails to establish an alternative etiology.

Adverse Reactions: The most common adverse reactions in clinical studies (≥ 3% of Aimovig®-treated patients and more often than placebo) were injection site reactions and constipation.

Please see accompanying Aimovig® full Prescribing Information

References: 1. Aimovig® (erenumab-aooe) Prescribing Information. Thousand Oaks, CA: Amgen Inc; 2020. 2. Mead J, et al. Patient Reported Ease of Use with Disposable Autoinjector in Individuals with Migraine. Patient Preference and Adherence. 2020:14 1137-1144.

© 2020 Amgen Inc. All rights reserved. USA-334-84118   09/20

  • Saved

Commented on 's Post

SUPPLEMENTS AND NATURAL TREATMENTS FOR MIGRAINE PREVENTION, EVERYTHING YOU NEED TO KNOW. - Headache Diagnosis Tool

SUPPLEMENTS AND NATURAL TREATMENTS FOR MIGRAINE PREVENTION, EVERYTHING YOU NEED TO KNOW. @Neuralgroover Worldwide, migraine affects more than 10-12% of the population, with approximately 700 million migraineurs estimated worldwide.1 It ..... see more

Source : https://virtualheadachespecialist.com/supplements-and-natural-treatments-for-migraine-prevention-everything-you-need-to-know/

  • Saved

Commented on 's Post

PREVENTATIVE MIGRAINE TREATMENT - WHEN TO START, WHICH TO START, AND WHEN TO STOP. - Headache Diagnosis Tool

PREVENTATIVE MIGRAINE TREATMENT - WHEN TO START, WHICH TO START, AND WHEN TO STOP. @Neuralgroover BACKGROUND Migraine is a very disruptive disorder to have to deal with. It interferes with ..... see more

Source : https://virtualheadachespecialist.com/preventative-migraine-treatment-when-to-start-which-to-start-and-when-to-stop/

  • Saved

Commented on 's Post

MENSTRUAL MIGRAINE TREATMENT TIPS AND CONTRACEPTION STROKE RISK. - Headache Diagnosis Tool

MENSTRUAL MIGRAINE TREATMENT TIPS AND CONTRACEPTION STROKE RISK. @Neuralgroover BACKGROUND Migraine is estimated to effect about 18% of women and 6% of men. That is a 3:1 ratio. Much of ..... see more

Source : https://virtualheadachespecialist.com/menstrual-migraine-treatment-tips-and-contraception-stroke-risk/

  • Saved

Commented on 's Post

Blog of Hot Topics and Headache Hacks - Headache Diagnosis Tool

BATTLE OF THE MONOCLONAL ANTIBODY CGRP ANTAGONISTS: AIMOVIG vs. AJOVY vs. EMGALITY vs. VYEPTI. WHAT ARE THE DIFFERENCES AND WHICH IS BEST FOR YOU? @Neuralgroover New blog coming soon, stay ..... see more

Source : https://virtualheadachespecialist.com/blog/

  • Saved

Commented on 's Post

The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response

Cookies are disabled for this browser. Wiley Online Library requires cookies for authentication and use of other site features; therefore, cookies must be enabled to browse the site. Detailed information ..... see more

Source : https://headachejournal.onlinelibrary.wiley.com/doi/full/10.1111/head.13929

  • Saved

Commented on 's Post

Intravenous sodium valproate for acute migraine in the emergency department: A meta‐analysis

The role of intravenous sodium valproate (iVPA) in acute migraine attack has not been completely established. The aim of this updated review was to evaluate the efficacy and safety of ..... see more

Source : https://onlinelibrary.wiley.com/doi/abs/10.1111/ane.13325?af=R

  • Saved

made a Post

Neurophysiological correlates of abnormal auditory processing in episodic migraine during the interictal period - PubMed

1 Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. 2 Headache Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, ..... see more

Source : https://pubmed.ncbi.nlm.nih.gov/32838536/

  • Saved

made a Post

PERSISTENT MIGRAINE AURA, VISUAL SNOW, MIGRAINOUS STROKE, AND WHAT YOU SHOULD KNOW. - Headache Diagnosis Tool

PERSISTENT MIGRAINE AURA, VISUAL SNOW, MIGRAINOUS STROKE, AND WHAT YOU SHOULD KNOW. @Neuralgroover INTRODUCTION The International Classification of Headache Disorders-3 (ICHD-3) classifies persistent aura without infarction (stroke) and migrainous infarction ..... see more

Source : https://virtualheadachespecialist.com/persistent-migraine-aura-visual-snow-migrainous-stroke-and-what-you-should-know/

  • Saved

made a Post

EVERYTHING YOU NEED TO KNOW ABOUT CBD (CANNABIDIOL) USE FOR MIGRAINE, HEADACHE, PAIN, AND OTHER CONDITIONS. - Headache Diagnosis Tool

EVERYTHING YOU NEED TO KNOW ABOUT CBD (CANNABIDIOL) USE FOR MIGRAINE, HEADACHE, PAIN, AND OTHER CONDITIONS. @Neuralgroover BACKGROUND CBD is everywhere! You can buy it at the local grocery store, ..... see more

Source : https://virtualheadachespecialist.com/everything-you-need-to-know-about-cbd-cannabidiol-use-for-migraine-headache-pain-and-other-conditions/

  • Saved

made a Post

HOW TO BREAK FREE FROM THE VICIOUS CYCLE OF REBOUND HEADACHE (MEDICATION OVERUSE HEADACHE). - Headache Diagnosis Tool

HOW TO BREAK FREE FROM THE VICIOUS CYCLE OF REBOUND HEADACHE (MEDICATION OVERUSE HEADACHE). @Neuralgroover Chronic daily headache being endlessly fueled and driven by rebound headache (medication overuse headache; MOH) ..... see more

Source : https://virtualheadachespecialist.com/how-to-break-free-from-the-vicious-cycle-of-rebound-headache-medication-overuse-headache/

  • Saved

made a Post

NOT ALL TRIPTANS ARE CREATED EQUAL. HOW TO FINE-TUNE WHICH WILL BE MOST EFFECTIVE FOR YOU. - Headache Diagnosis Tool

NOT ALL TRIPTANS ARE CREATED EQUAL. HOW TO FINE-TUNE WHICH WILL BE MOST EFFECTIVE FOR YOU. @Neuralgroover Since 1992, the triptans have been the first and only migraine specific abortive ..... see more

Source : https://virtualheadachespecialist.com/not-all-triptans-are-created-equal-this-is-how-to-fine-tune-which-triptan-will-be-most-effective-for-you/

  • Saved

made a Post

CHIARI MALFORMATION HEADACHE, AND WHY YOU MAY STILL HAVE A DAILY HEADACHE FOLLOWING CHIARI DECOMPRESSION SURGERY. - Headache Diagnosis Tool

CHIARI MALFORMATION HEADACHE, AND WHY YOU MAY STILL HAVE A DAILY HEADACHE FOLLOWING CHIARI DECOMPRESSION SURGERY. @Neuralgroover Chiari malformation is a common anatomical variation, specifically type I which this blog ..... see more

Source : https://virtualheadachespecialist.com/chiari-malformation-headache-and-why-you-may-still-have-a-daily-headache-following-decompression/

  • Saved

made a Post

  • Saved

Commented on 's Post

Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A i... - PubMed - NCBI

AbstractBACKGROUND:To evaluate the efficacy of botulinum toxin A (BoNT-A) in reducing photophobia and dry eye symptoms in individuals with chronic migraine. Additionally, we aimed to evaluate tear film volume as ..... see more

Source : https://www.ncbi.nlm.nih.gov/pubmed/30269099